A NEW-GENERATION OF STARCH PRODUCTS AS EXCIPIENT IN PHARMACEUTICAL TABLETS .2. HIGH-SURFACE-AREA RETROGRADED PREGELATINIZED POTATO STARCH PRODUCTS IN SUSTAINED-RELEASE TABLETS
Ghp. Tewierik et al., A NEW-GENERATION OF STARCH PRODUCTS AS EXCIPIENT IN PHARMACEUTICAL TABLETS .2. HIGH-SURFACE-AREA RETROGRADED PREGELATINIZED POTATO STARCH PRODUCTS IN SUSTAINED-RELEASE TABLETS, Journal of controlled release, 45(1), 1997, pp. 25-33
A new linear short-chain starch product was prepared by gelatinization
of potato starch followed by enzymatic degradation, precipitation (re
trogradation) and filtration. A high specific surface area was subsequ
ently created by washing with ethanol or acetone or freeze-drying. Tab
lets compressed from a mixture containing the starch product and 30% t
heophylline at a force of at least 15 kN showed no disintegration and
an almost constant (zero-order) sustained drug release. The delivery f
rom these non-porous tablets proved to be a swelling-controlled solven
t-activated mechanism, as was confirmed by the slow penetration of a s
olvent front into the tablet. Drug release proved to be not affected b
y the incorporation of magnesium stearate into the tablet or the prese
nce of alpha-amylase in the dissolution medium, both features in contr
ast to similar tablets compressed from conventional pregelatinized sta
rches, which were prepared by gelatinization followed directly by ther
mic dehydration. A specific surface area of 1.5 m(2)/g proved to be a
prerequisite for the starch product to control drug release. A high su
rface area (linear long-chain) amylose product showed a sustained but
less linear release profile. Branched short and long-chain products wi
th a high surface area produced disintegrating tablets and are therefo
re not able to control drug release.